GHO Capital appoints Olav König as Head of Investor Relations GHO Capital Updates GHO Capital appoints Olav König as Head of Investor Relations
Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies Biocare Medical Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies
GHO Capital and CBC Group to Create World’s Largest Dedicated Healthcare Investment Firm GHO Capital Updates GHO Capital and CBC Group to Create World’s Largest Dedicated Healthcare Investment Firm
Alcami to Acquire Contract Packaging Organization Tjoapack Alcami Alcami to Acquire Contract Packaging Organization Tjoapack
GHO Capital completes sale of VISUfarma to Lupin VISUfarma GHO Capital completes sale of VISUfarma to Lupin
GHO Capital and Excellere Partners Sell Biocare Medical to Agilent Technologies Biocare Medical GHO Capital and Excellere Partners Sell Biocare Medical to Agilent Technologies
GHO Capital announces final close of Fund IV with over €2.5bn of capital to continue investing in its strategy of driving better, faster and more accessible healthcare GHO Capital Updates GHO Capital announces final close of Fund IV with over €2.5bn of capital to continue investing in its strategy of driving better, faster and more accessible healthcare
GHO Capital closes €660 million private equity fund GHO Capital Updates GHO Capital closes €660 million private equity fund
Caprion Biosciences Acquires the Immune Monitoring Laboratory from ImmuneHealth Caprion Biosciences Caprion Biosciences Acquires the Immune Monitoring Laboratory from ImmuneHealth
GHO Capital announces acquisition of Caprion Biosciences Caprion Biosciences GHO Capital announces acquisition of Caprion Biosciences
GHO Capital & Ardian team with Envision leadership to acquire the Envision Pharma Group from the Halifax Group Envision Pharma Group GHO Capital & Ardian team with Envision leadership to acquire the Envision Pharma Group from the Halifax Group
GHO Capital announces two acquisitions to create pan-European ophthalmic specialty pharmaceutical company VISUfarma GHO Capital announces two acquisitions to create pan-European ophthalmic specialty pharmaceutical company
Ken Eichmann joins GHO Capital as Principal GHO Capital Updates Ken Eichmann joins GHO Capital as Principal
GHO Capital announces acquisition of DNA Diagnostics Center DDC GHO Capital announces acquisition of DNA Diagnostics Center
GHO Capital supports European Medicines Agency’s “Science, Medicines, Health: Patients at the heart of future innovation” conference GHO Capital Updates GHO Capital supports European Medicines Agency’s “Science, Medicines, Health: Patients at the heart of future innovation” conference
